| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 786,363 | 764,183 | 923,493 | 946,962 | | Cost of Revenue | 285,961 | 268,512 | 304,270 | 307,579 | | | Gross Profit | 500,402 | 495,671 | 619,223 | 639,383 | | | Operating Expenses | | Research Development | 183,894 | 185,400 | 180,134 | 194,014 | | Selling General and Administrative | 209,750 | 220,454 | 244,025 | 238,223 | | Non Recurring | 7,529 | 4,229 | 4,979 |
-
| | Others | 3,539 | 4,390 | 211 | 5,190 | | | | Total Operating Expenses | 404,712 | 414,473 | 429,349 |
-
| | | | Operating Income or Loss | 95,690 | 81,198 | 189,874 | 201,956 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,273 | 264 | (6,600) | 9,740 | | Earnings Before Interest And Taxes | 96,963 | 81,462 | 184,773 | 211,696 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 96,963 | 81,462 | 184,773 | 211,696 | | Income Tax Expense | 82,194 | 85,922 | 52,297 | 63,188 | | Minority Interest |
-
|
-
| 1,499 | (1,499) | | | | Net Income From Continuing Ops | 14,769 | (4,460) | 132,476 | 148,508 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,769 | (4,460) | 132,476 | 148,508 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,769 | ($4,460) | $132,476 | $148,508 |
|
0.06% Nasdaq 
Income Statement
